Telephone Counseling and Numberless Scales to Overcome Barriers to Adolescent Weight Loss

Brief Telephone Counseling and Numberless Scales to Overcome Weight Loss Barriers in Underserved Adolescents

This study tests the feasibility and acceptability of a numberless behavioral digital scale (BDS) intervention combined with motivational interviewing (MI) to affect lifestyle changes to promote weight loss in adolescents who are obese. Half of the participants will receive this intervention, while the other half will use a digital scale along with the standard adolescent weight loss program.

Study Overview

Detailed Description

The proposed pilot project seeks to enhance motivation for lifestyle change in adolescents who are obese. It will test a novel intervention that combines modified MI-based counseling and BDS. We will test the feasibility of the intervention over a 12-week period, with 24-week follow-up compared to use of standard digital scale. All participants will undergo the standard adolescent weight loss program, which includes monthly clinic visits with dietary and physical activity counseling. The MI intervention will include modified MI, brief weekly telephone reinforcement, and use of a BDS. The BDS with its mobile app offers daily feedback through colors, daily missions to promote healthy habits, and weekly healthy tips from nutritionists. In addition to the primary outcome of feasibility (daily weighing) investigators will also explore the intervention's effect on motivation, psychological outcomes and various aspects of feasibility and acceptability.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • League City, Texas, United States, 77573
        • UTMB
      • Webster, Texas, United States, 77598
        • UTMB

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age between 12 and 18 years
  • BMI greater than or equal to 95th percentile for age and sex group or BMI greater than or equal to 35 kg/m^2
  • Participant (not parent) is able to read and understand English (app is in English)
  • Smartphone device with Wi-Fi and app capability
  • Willingness to be randomized to any condition

Exclusion Criteria:

Age 19 years or older

  • Developmental delay
  • Inability to provide informed consent
  • Any medical condition that, in the opinion of the PI, would place the participant at increased risk
  • Use of an investigational agent in the 30 days prior to signing informed consent
  • History of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction) that would , in the opinion of the PI, make it difficult for the participant to comply with study procedures or follow instructions
  • Females who are pregnant or lactating, by verbal report
  • Pre-existing conditions (i.e paralysis, heart failure, severe autism or mental retardation, psychosis, etc.)
  • Prisoners
  • Lack of transportation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Numberless BDS and Modified-MI
Use of numberless BDS (color coded), app, and motivational interviewing. Participants will weigh daily and receive weekly motivational interviewing at clinic visits and via a weekly phone call.
Participants perform daily weighing using a numberless BDS with feedback from app (color codes, challenges), in conjunction with modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.
Modified motivational interviewing (clinic visits and weekly telephone calls), and the standard adolescent weight loss program.
Active Comparator: Digital Scale
Use standard digital scale (number readout). Participants will weigh daily.
Participants perform daily weighing using a digital scale (number readout), in conjunction with standard adolescent weight loss program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of Modified MI and BDS
Time Frame: 24 weeks
Attendance at in-clinic visits, completion of weekly phone calls, and daily weighing based on BDS app data collected at 24 week assessment.
24 weeks
Acceptability of Modified MI and BDS
Time Frame: 24 weeks
Number of participants in each group who are lost to follow-up
24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometrics
Time Frame: 24 weeks
Body Mass Index (BMI)
24 weeks
Bio-impedence measures
Time Frame: 24 weeks
Measures body fat (%)
24 weeks
Anxiety
Time Frame: Change from 0 to 24 weeks
Self-reported anxiety on a scale from 0 (not at all) to 3 (severely) using the Beck Anxiety Inventory
Change from 0 to 24 weeks
Depression
Time Frame: Change from 0 to 24 weeks
Self-reported depression screening on a scale from 0 (not at all) to 3 (nearly every day) using the PHQ-9: Modified for Teens
Change from 0 to 24 weeks
Bio-impedence measures
Time Frame: 24 weeks
Measures muscle mass (%)
24 weeks
Bio-impedence measures
Time Frame: 24 weeks
Measures visceral fat (%)
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kanika Bowen-Jallow, MD, MMS, University of Texas

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 14, 2020

Primary Completion (Actual)

September 14, 2020

Study Completion (Actual)

September 14, 2020

Study Registration Dates

First Submitted

January 9, 2020

First Submitted That Met QC Criteria

January 22, 2020

First Posted (Actual)

January 27, 2020

Study Record Updates

Last Update Posted (Actual)

November 9, 2020

Last Update Submitted That Met QC Criteria

November 6, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 19-0198
  • K12HD052023 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The investigators will provide access to all data, regardless of publication, collected on this project. All external investigators must supply a written request identifying their research questions (s) and specifying the data they would like to analyze. The request must include a data security plan and explanation of how the data would be stored and who would have access.

IPD Sharing Time Frame

Data available upon request

IPD Sharing Access Criteria

All external investigators must supply a written request identifying their research questions (s) and specifying the data they would like to analyze. The request must include a data security plan and explanation of how the data would be stored and who would have access.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Numberless BDS

3
Subscribe